المؤلفون: Thomas M, Spigel DR, Jotte RM, McCleod M, Socinski MA, Page RD, Gressot L, Knoble J, Juan O, Morgensztern D, Isla D, Kim ES, West H, Ko A, Ong TJ, Trunova N, Gridelli C

المصدر: Lung Cancer: Targets and Therapy, Vol Volume 8, Pp 207-216 (2017)

مصطلحات موضوعية: nab-paclitaxel, non-small cell lung cancer, quality of life, response, squamous, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.dovepress.com/nab-paclitaxelcarboplatin-induction-in-squamous-nsclc-longitudinal-qua-peer-reviewed-article-LCTT; https://doaj.org/toc/1179-2728

URL الوصول: https://doaj.org/article/e012459543d645ccac9379a0cc907457

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Witta SE, Jotte RM, Konduri K, Neubauer MA, Spira AI, Ruxer RL, Varella-Garcia M, Bunn PA Jr, Hirsch FR, Witta, Samir E, Jotte, Robert M, Konduri, Katrik, Neubauer, Marcus A, Spira, Alexander I, Ruxer, Robert L, Varella-Garcia, Marileila, Bunn, Paul A Jr, Hirsch, Fred R

المصدر: Journal of Clinical Oncology; 6/20/2012, Vol. 30 Issue 18, p2248-2255, 8p

المؤلفون: Blumenschein GR Jr, Khuri FR, von Pawel J, Gatzemeier U, Miller WH Jr, Jotte RM, Le Treut J, Sun SL, Zhang JK, Dziewanowska ZE, Negro-Vilar A

المصدر: Journal of Clinical Oncology; 4/10/2008, Vol. 26 Issue 11, p1879-1885, 7p

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Socinski MA; AdventHealth Cancer Institute, Orlando, Florida., Jotte RM; Rocky Mountain Cancer Centers, Denver, Colorado.; US Oncology, Houston, Texas., Cappuzzo F; Istituto Nazionale Tumori IRCCS Regina Elena, Roma, Italy., Nishio M; The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Mok TSK; State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong., Reck M; Lung Clinic Grosshansdorf, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany., Finley GG; Allegheny Health Network Cancer Institute, Pittsburgh, Pennsylvania., Kaul MD; Genentech, Inc, South San Francisco, California., Yu W; Genentech, Inc, South San Francisco, California., Paranthaman N; Genentech, Inc, South San Francisco, California., Bara I; Genentech, Inc, South San Francisco, California., West HJ; City of Hope Comprehensive Cancer Center, Duarte, California.

المصدر: JAMA oncology [JAMA Oncol] 2023 Apr 01; Vol. 9 (4), pp. 527-535.

نوع المنشور: Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Lung Neoplasms*, Adult ; Humans ; Male ; Middle Aged ; Female ; Bevacizumab/therapeutic use ; Carboplatin/adverse effects ; Randomized Controlled Trials as Topic ; Paclitaxel/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects

المؤلفون: West HJ; Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California, USA jackwestmd@gmail.com., McCleland M; Genentech Inc, South San Francisco, California, USA., Cappuzzo F; Oncology Department, Istituto Nazionale Tumori 'Regina Elena', Rome, Italy., Reck M; Department of Thoracic Oncology, LungenClinic Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany., Mok TS; State Key Laboratory of Translational Oncology, Department of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong, China., Jotte RM; Department of Medical Oncology, Rocky Mountain Cancer Centers, Denver, Colorado, USA.; US Oncology, Houston, Texas, USA., Nishio M; Thoracic Medical Oncology Department, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan., Kim E; Genentech Inc, South San Francisco, California, USA., Morris S; Product Development Medical Affairs, F Hoffmann-La Roche Ltd, Basel, Switzerland., Zou W; Genentech Inc, South San Francisco, California, USA., Shames D; Genentech Inc, South San Francisco, California, USA., Das Thakur M; Genentech Inc, South San Francisco, California, USA., Shankar G; Genentech Inc, South San Francisco, California, USA., Socinski MA; Thoracic Oncology, AdventHealth Cancer Institute, Orlando, Florida, USA.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Feb; Vol. 10 (2).

نوع المنشور: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: AMP-Activated Protein Kinase Kinases/*metabolism , Antibodies, Monoclonal, Humanized/*therapeutic use , Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Bevacizumab/*therapeutic use , Carcinoma, Non-Small-Cell Lung/*drug therapy , Kelch-Like ECH-Associated Protein 1/*metabolism , Lung Neoplasms/*drug therapy , Tumor Suppressor Protein p53/*metabolism, Adult ; Antibodies, Monoclonal, Humanized/pharmacology ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Bevacizumab/pharmacology ; Carcinoma, Non-Small-Cell Lung/mortality ; Carcinoma, Non-Small-Cell Lung/pathology ; Female ; Humans ; Lung Neoplasms/mortality ; Lung Neoplasms/pathology ; Middle Aged ; Mutation ; Prognosis ; Progression-Free Survival ; Retrospective Studies